As costs escalate, demographics shift and regulatory complexities increase, life sciences companies can’t hold on to the past — new approaches are needed to deliver personalized care and better health outcomes faster and with greater efficiency.
34,500+
life sciences practitioners worldwide are ready to help clients today.
8,400+
global life sciences clients trust EY to help them demonstrate greater value.
US$1b+
annual investment in data, tech and AI to solve complex client challenges.
Companies need acquisitions and alliances to build their portfolios. With heavy competition for assets across a widening frontier of innovation, companies need to partner more effectively across a wider range of both technologies and geographies.
HOW EY CAN HELP
EY helps life sciences’ clients partner across the innovation ecosystem to accelerate growth, enhance agility, reduce time-to-market and scale impactful innovations.
FEATURED
EY Firepower report: life sciences dealmaking – trends in 2026
Dealmaking will continue to be driven not by market variations but by strategic fundamentals.
Reducing costs and optimizing operations remains a top priority, across back-office functions from Global Business Services (GBS) to risk, regulatory and other processes. Agentic AI has emerged as a key lever for streamlining operations and protecting margins.
HOW EY CAN HELP
EY supports life sciences clients in achieving operational efficiency by helping them to optimize end-to-end value chain to control costs, ensure product/service quality and adherence to regulations, and fund innovation.
FEATURED
How life sciences legal teams prepare for a technology-driven future
Advances in healthcare technology create new data flows for life sciences companies, shifting the landscape for legal departments.
The industry’s manufacturing model faces onshoring pressures, soaring logistical costs, supply vulnerabilities and counterfeiting challenges. Companies need a smarter, AI-assisted digital manufacturing model that can ensure supply chain security, visibility, agility and operational resilience.
HOW EY CAN HELP
EY helps life sciences clients improve supply and demand synchronization via advanced analytics and the creation of new adaptive manufacturing capability.
FEATURED
How AI is supporting pharmaceutical manufacturing and supply chain
In this episode of the EY Health Sciences and Wellness Experience podcast, host Patrick T. O’Sullivan discusses how AI is currently being used to support pharmaceutical manufacturing and supply chain.
With development delays, failing launches and payer pushback, companies must bring commercial excellence into the end-to-end product lifecycle: accelerating from research and development to commercialization, leveraging next-generation Customer Relationship Management (CRM), and measuring real-world outcomes to support reimbursement.
HOW EY CAN HELP
EY helps life sciences implement new technologies and AI-powered solutions that enable holistic, high-quality care, products, services, and support digitized service models and operations.
FEATURED
How biopharma can get the right mix of people and tech for launch success
Facing a challenging commercial environment, biopharma companies need to embrace an end-to-end, AI-driven strategy to succeed.
Explore our offerings
The EY Promotional Content Management Services team can provide you with support that will transform your processes and improve your results. Learn more.
Read more
The EY Health Outcomes Platform aligns all stakeholders by providing a practical solution to operate value-based contracts at scale. Find out how.
Read more
The EY Smart Reviewer can help your business accelerate and optimize the review and approval process for marketing and promotional materials. Find out how.
Read more
Our Biopharma Launch Edge team can help your business achieve successful launches. Find out how.
Read more
The EY-Parthenon Healthcare Strategy Consulting team help organizations develop digital, transaction and value strategies to build resilience and drive future growth.
Read moreEY-Parthenon: Transformative strategy and transactions – solutions that work in practice, not just on paper.
EY harnesses a connected ecosystem of strategic alliances and partnerships to co-create value and deliver comprehensive technology solutions and business outcomes for our clients.
Our latest thinking
How the global IPO market proved its resilience in Q3
The EY Global IPO Trends Q3 2026 highlights the market’s resilience as sector participation broadens amid ongoing geopolitical and economic challenges.
How next-generation CRM will reshape the life sciences commercial model
CRM must evolve from analogue maps to real-time GPS for pharma. Unlock deeper insights—transform your customer engagement now. Read more.
How Medtronic’s optimized supply chain gets products to patients in need
A global technology Life Sciences leader improved their supply chain planning to better serve patients. Learn more in this case study.
How IntraBio's finance transformation fueled its global expansion
For its global expansion, IntraBio needed to solve operational and financial back-office challenges. Learn how EY finance transformation services helped.
EY Firepower report: life sciences dealmaking – trends in 2026
Learn how life sciences organizations can accelerate dealmaking strategies to succeed.
How Bayer is unearthing agronomy's future with generative AI
Read this case study to learn how Bayer Crop Science is using large language models to plant the seeds of the future.
Explore related sector pages: Consumer Products | Health | Retail